| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 724 | 1.282 | 5.179 | 5.295 | 3.393 | 4.384 | 9.712 |
| Total Income - EUR | - | - | - | 724 | 1.282 | 5.179 | 6.535 | 3.393 | 4.384 | 9.712 |
| Total Expenses - EUR | - | - | - | 225 | 886 | 1.992 | 3.065 | 3.932 | 2.383 | 5.143 |
| Gross Profit/Loss - EUR | - | - | - | 499 | 396 | 3.187 | 3.470 | -539 | 2.001 | 4.569 |
| Net Profit/Loss - EUR | - | - | - | 477 | 357 | 3.032 | 3.297 | -641 | 1.681 | 3.800 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bioelixir Concept S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 1.427 | 2.149 |
| Current Assets | - | - | - | 616 | 906 | 4.076 | 7.099 | 6.493 | 7.591 | 10.709 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 1.069 | 1.063 |
| Receivables | - | - | - | 0 | 0 | 6 | 6 | 6 | 6 | 6 |
| Cash | - | - | - | 616 | 906 | 4.070 | 7.093 | 6.487 | 6.516 | 9.640 |
| Shareholders Funds | - | - | - | 520 | 868 | 3.883 | 7.094 | 6.475 | 8.136 | 11.891 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 95 | 39 | 193 | 5 | 18 | 882 | 968 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Bioelixir Concept S.r.l.